Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 89

1.

Modeling human bladder cancer.

Ringuette-Goulet C, Bolduc S, Pouliot F.

World J Urol. 2018 Jun 14. doi: 10.1007/s00345-018-2369-5. [Epub ahead of print]

PMID:
29948049
2.

Engineering Tissues without the Use of a Synthetic Scaffold: A Twenty-Year History of the Self-Assembly Method.

Saba I, Jakubowska W, Bolduc S, Chabaud S.

Biomed Res Int. 2018 Mar 8;2018:5684679. doi: 10.1155/2018/5684679. eCollection 2018. Review.

3.

Exosomes Induce Fibroblast Differentiation into Cancer-Associated Fibroblasts through TGFβ Signaling.

Ringuette Goulet C, Bernard G, Tremblay S, Chabaud S, Bolduc S, Pouliot F.

Mol Cancer Res. 2018 Jul;16(7):1196-1204. doi: 10.1158/1541-7786.MCR-17-0784. Epub 2018 Apr 10.

PMID:
29636362
4.

Adherence to antimuscarinics in children with overactive bladder.

Fortin A, Morin V, Ramsay S, Gervais P, Bolduc S.

Paediatr Child Health. 2017 Aug;22(5):255-258. doi: 10.1093/pch/pxx055. Epub 2017 May 17.

5.

Tissue-engineered human 3D model of bladder cancer for invasion study and drug discovery.

Ringuette Goulet C, Bernard G, Chabaud S, Couture A, Langlois A, Neveu B, Pouliot F, Bolduc S.

Biomaterials. 2017 Nov;145:233-241. doi: 10.1016/j.biomaterials.2017.08.041. Epub 2017 Aug 29.

PMID:
28888113
6.

Dimercaptosuccinic acid scintigraphy vs. ultrasound for renal parenchymal defects in children.

Marceau-Grimard M, Marion A, Côté C, Bolduc S, Dumont M, Moore K.

Can Urol Assoc J. 2017 Aug;11(8):260-264. doi: 10.5489/cuaj.4257.

7.

Long-Term Safety and Efficacy of Solifenacin in Children and Adolescents with Overactive Bladder.

Newgreen D, Bosman B, Hollestein-Havelaar A, Dahler E, Besuyen R, Snijder R, Sawyer W, Rittig S, Bolduc S.

J Urol. 2017 Oct;198(4):928-936. doi: 10.1016/j.juro.2017.05.038. Epub 2017 May 12.

PMID:
28506854
8.

Overactive bladder in children.

Ramsay S, Bolduc S.

Can Urol Assoc J. 2017 Jan-Feb;11(1-2Suppl1):S74-S79. doi: 10.5489/cuaj.4337. Review.

9.

Vesicoureteral reflux: From prophylaxis to surgery.

Blais AS, Bolduc S, Moore K.

Can Urol Assoc J. 2017 Jan-Feb;11(1-2Suppl1):S13-S18. doi: 10.5489/cuaj.4342. Review.

10.

Urothelial cell expansion and differentiation are improved by exposure to hypoxia.

Chabaud S, Saba I, Baratange C, Boiroux B, Leclerc M, Rousseau A, Bouhout S, Bolduc S.

J Tissue Eng Regen Med. 2017 Nov;11(11):3090-3099. doi: 10.1002/term.2212. Epub 2017 Feb 3.

PMID:
28156053
11.

Dual Therapy for Refractory Overactive Bladder in Children: A Prospective Open-Label Study.

Morin F, Blais AS, Nadeau G, Moore K, Genois L, Bolduc S.

J Urol. 2017 Apr;197(4):1158-1163. doi: 10.1016/j.juro.2016.11.101. Epub 2016 Nov 30.

PMID:
27914999
12.

Solifenacin in Children and Adolescents with Overactive Bladder: Results of a Phase 3 Randomised Clinical Trial.

Newgreen D, Bosman B, Hollestein-Havelaar A, Dahler E, Besuyen R, Sawyer W, Bolduc S, Rittig S.

Eur Urol. 2017 Mar;71(3):483-490. doi: 10.1016/j.eururo.2016.08.061. Epub 2016 Sep 28.

PMID:
27687820
13.

Polyacrylamide Hydrogel as a Bulking Agent for the Endoscopic Treatment of Vesicoureteral Reflux: Long-Term Results and Safety.

Ramsay S, Blais AS, Morin F, Moore K, Cloutier J, Bolduc S.

J Urol. 2017 Mar;197(3 Pt 2):963-967. doi: 10.1016/j.juro.2016.08.093. Epub 2016 Aug 26.

PMID:
27575606
14.

Novel three-dimensional autologous tissue-engineered vaginal tissues using the self-assembly technique.

Orabi H, Saba I, Rousseau A, Bolduc S.

Transl Res. 2017 Feb;180:22-36. doi: 10.1016/j.trsl.2016.07.019. Epub 2016 Aug 1.

PMID:
27543901
15.

Origin of Serum Affects Quality of Engineered Tissues Produced by the Self-Assembly Approach.

Chabaud S, Simard M, Gendreau I, Pouliot R, Bolduc S.

Scientifica (Cairo). 2016;2016:3825645. doi: 10.1155/2016/3825645. Epub 2016 May 16.

16.

Anticholinergic use in children: Persistence and patterns of therapy.

Blais AS, Bergeron M, Nadeau G, Ramsay S, Bolduc S.

Can Urol Assoc J. 2016 Mar-Apr;10(3-4):137-40. doi: 10.5489/cuaj.3527.

17.

Clinical challenges in tissue-engineered urethral reconstruction.

Ramsay S, Ringuette-Goulet C, Langlois A, Bolduc S.

Transl Androl Urol. 2016 Apr;5(2):267-70. doi: 10.21037/tau.2016.01.11. No abstract available.

18.

Production of a Self-Aligned Scaffold, Free of Exogenous Material, from Dermal Fibroblasts Using the Self-Assembly Technique.

Chabaud S, Bolduc S.

Dermatol Res Pract. 2016;2016:5397319. doi: 10.1155/2016/5397319. Epub 2016 Mar 9.

19.

Prospective Pilot Study of Mirabegron in Pediatric Patients with Overactive Bladder.

Blais AS, Nadeau G, Moore K, Genois L, Bolduc S.

Eur Urol. 2016 Jul;70(1):9-13. doi: 10.1016/j.eururo.2016.02.007. Epub 2016 Feb 11.

PMID:
26876327
20.

Erratum to: Maintenance of bladder urothelia integrity and successful urothelialization of various tissue-engineered mesenchymes in vitro.

Bouhout S, Tremblay J, Bolduc S.

In Vitro Cell Dev Biol Anim. 2015 Oct;51(9):932. doi: 10.1007/s11626-015-9955-2. No abstract available.

PMID:
26427707
21.

Demonstration of the direct impact of ketamine on urothelium using a tissue engineered bladder model.

Bureau M, Pelletier J, Rousseau A, Bernard G, Chabaud S, Bolduc S.

Can Urol Assoc J. 2015 Sep-Oct;9(9-10):E613-7. doi: 10.5489/cuaj.2899. Epub 2015 Sep 9.

22.

Optimization of the current self-assembled urinary bladder model: Organ-specific stroma and smooth muscle inclusion.

Orabi H, Rousseau A, Laterreur V, Bolduc S.

Can Urol Assoc J. 2015 Sep-Oct;9(9-10):E599-607. doi: 10.5489/cuaj.2953. Epub 2015 Sep 9.

23.

Efficacy of dextranomer hyaluronic acid and polyacrylamide hydrogel in endoscopic treatment of vesicoureteral reflux: A comparative study.

Blais AS, Morin F, Cloutier J, Moore K, Bolduc S.

Can Urol Assoc J. 2015 May-Jun;9(5-6):202-6. doi: 10.5489/cuaj.2964.

24.

Maintenance of bladder urothelia integrity and successful urothelialization of various tissue-engineered mesenchymes in vitro.

Bouhout S, Tremblay J, Bolduc S.

In Vitro Cell Dev Biol Anim. 2015 Oct;51(9):922-31. doi: 10.1007/s11626-015-9923-x. Epub 2015 Jun 20. Erratum in: In Vitro Cell Dev Biol Anim. 2015 Oct;51(9):932.

PMID:
26091628
25.

Inexpensive production of near-native engineered stromas.

Chabaud S, Rousseau A, Marcoux TL, Bolduc S.

J Tissue Eng Regen Med. 2017 May;11(5):1377-1389. doi: 10.1002/term.2036. Epub 2015 May 26.

PMID:
26010652
26.

Organ-specific matrix self-assembled by mesenchymal cells improves the normal urothelial differentiation in vitro.

Bouhout S, Chabaud S, Bolduc S.

World J Urol. 2016 Jan;34(1):121-30. doi: 10.1007/s00345-015-1596-2. Epub 2015 May 26.

PMID:
26008115
27.

A Novel and Faster Method to Obtain a Differentiated 3-Dimensional Tissue Engineered Bladder.

Bouhout S, Goulet F, Bolduc S.

J Urol. 2015 Sep;194(3):834-41. doi: 10.1016/j.juro.2015.03.001. Epub 2015 Mar 7.

PMID:
25758608
28.

Anticancer properties of chitosan on human melanoma are cell line dependent.

Gibot L, Chabaud S, Bouhout S, Bolduc S, Auger FA, Moulin VJ.

Int J Biol Macromol. 2015 Jan;72:370-9. doi: 10.1016/j.ijbiomac.2014.08.033. Epub 2014 Sep 2.

PMID:
25193096
29.

Evaluating rain gardens as a method to reduce the impact of sewer overflows in sources of drinking water.

Autixier L, Mailhot A, Bolduc S, Madoux-Humery AS, Galarneau M, Prévost M, Dorner S.

Sci Total Environ. 2014 Nov 15;499:238-47. doi: 10.1016/j.scitotenv.2014.08.030. Epub 2014 Sep 3.

PMID:
25192930
30.

Double anticholinergic therapy for refractory neurogenic and nonneurogenic detrusor overactivity in children: Long-term results of a prospective open-label study.

Nadeau G, Schröder A, Moore K, Genois L, Lamontagne P, Hamel M, Pellerin E, Bolduc S.

Can Urol Assoc J. 2014 May;8(5-6):175-80. doi: 10.5489/cuaj.1362.

31.

Prospective study of polydimethylsiloxane vs dextranomer/hyaluronic acid injection for treatment of vesicoureteral reflux.

Moore K, Bolduc S.

J Urol. 2014 Dec;192(6):1794-9. doi: 10.1016/j.juro.2014.05.116. Epub 2014 Jun 10.

PMID:
24928269
32.

Intrascrotal extratesticular schwannoma: A first pediatric case.

Bergeron M, Bolduc S, Labonté S, Moore K.

Can Urol Assoc J. 2014 Mar;8(3-4):E279-81. doi: 10.5489/cuaj.1823.

33.

Long-term use of solifenacin in pediatric patients with overactive bladder: Extension of a prospective open-label study.

Nadeau G, Schröder A, Moore K, Genois L, Lamontagne P, Hamel M, Pellerin E, Bolduc S.

Can Urol Assoc J. 2014 Mar;8(3-4):118-23. doi: 10.5489/cuaj.1356.

34.

Learning curve for TIP urethroplasty: A single-surgeon experience.

Rompré MP, Nadeau G, Moore K, Ajjaouj Y, Braga LH, Bolduc S.

Can Urol Assoc J. 2013 Nov-Dec;7(11-12):E789-94. doi: 10.5489/cuaj.1376.

35.

Tissue engineering of urinary bladder and urethra: advances from bench to patients.

Orabi H, Bouhout S, Morissette A, Rousseau A, Chabaud S, Bolduc S.

ScientificWorldJournal. 2013 Dec 24;2013:154564. doi: 10.1155/2013/154564. eCollection 2013. Review.

36.

Adipose-derived stromal cells for the reconstruction of a human vesical equivalent.

Rousseau A, Fradette J, Bernard G, Gauvin R, Laterreur V, Bolduc S.

J Tissue Eng Regen Med. 2015 Nov;9(11):E135-43. doi: 10.1002/term.1717. Epub 2013 Apr 11.

PMID:
23576338
37.

Prospective study using a new bulking agent for the treatment of vesicoureteral reflux: polyacrylamide hydrogel.

Cloutier J, Blais AS, Moore K, Bolduc S.

J Urol. 2013 Sep;190(3):1034-7. doi: 10.1016/j.juro.2013.03.071. Epub 2013 Mar 26.

PMID:
23538241
38.

Lysophosphatidic acid enhances collagen deposition and matrix thickening in engineered tissue.

Chabaud S, Marcoux TL, Deschênes-Rompré MP, Rousseau A, Morissette A, Bouhout S, Bernard G, Bolduc S.

J Tissue Eng Regen Med. 2015 Nov;9(11):E65-75. doi: 10.1002/term.1711. Epub 2013 Feb 18.

PMID:
23418181
39.

An endothelialized urothelial cell-seeded tubular graft for urethral replacement.

Imbeault A, Bernard G, Rousseau A, Morissette A, Chabaud S, Bouhout S, Bolduc S.

Can Urol Assoc J. 2013 Jan-Feb;7(1-2):E4-9. doi: 10.5489/cuaj.12217.

40.

Characteristics of colored passive layers on zirconium: morphology, optical properties, and corrosion resistance.

Holmberg RJ, Bolduc S, Beauchemin D, Jerkiewicz G, Schulz H, Kohlhaas U, Strzelecki H.

ACS Appl Mater Interfaces. 2012 Dec;4(12):6487-98. doi: 10.1021/am301389u. Epub 2012 Nov 1.

PMID:
23088502
41.

Is an initial endoscopic treatment for all ureteroceles appropriate?

Boucher A, Cloutier J, Rousseau A, Charrois R, Bolduc S.

J Pediatr Urol. 2013 Jun;9(3):339-43. doi: 10.1016/j.jpurol.2012.04.009. Epub 2012 Jun 9.

PMID:
22687344
42.

A rare testicular solid mass in children: Juvenile granulosa cell tumour of testis.

Couture J, Bolduc S.

Can Urol Assoc J. 2012 Apr;6(2):E101-3. doi: 10.5489/cuaj.10176.

43.

Bilateral renal cell carcinoma in a child.

Cloutier J, Aziz A, Inman B, Bolduc S.

Urology. 2012 Aug;80(2):430-3. doi: 10.1016/j.urology.2012.01.015. Epub 2012 Mar 3.

PMID:
22386253
44.

Hydrophilic-coated catheter appreciation study in a pediatric population.

Boucher A, Cloutier J, Lebel S, Hamel M, Lamontagne P, Bolduc S.

Can Urol Assoc J. 2010 Dec;4(6):e150-4.

45.

Surgical option for the correction of Peyronie's disease: an autologous tissue-engineered endothelialized graft.

Imbeault A, Bernard G, Ouellet G, Bouhout S, Carrier S, Bolduc S.

J Sex Med. 2011 Nov;8(11):3227-35. doi: 10.1111/j.1743-6109.2011.02374.x. Epub 2011 Jun 30.

PMID:
21718447
46.

Allantoic cysts and posterior urethral valves: a case report.

Bureau M, Bolduc S.

Ultrasound Obstet Gynecol. 2011 Jul;38(1):116-8. doi: 10.1002/uog.8910.

47.

Mechanical stimuli-induced urothelial differentiation in a human tissue-engineered tubular genitourinary graft.

Cattan V, Bernard G, Rousseau A, Bouhout S, Chabaud S, Auger FA, Bolduc S.

Eur Urol. 2011 Dec;60(6):1291-8. doi: 10.1016/j.eururo.2011.05.051. Epub 2011 Jun 12.

PMID:
21684066
48.

Variation spatiotemporelle de la cryptorchidie et de l'hypospadias au Québec : Une étude exploratoire.

Guertin S, Lemieux KS, Makhoulian N, Michaud S, Patry RM, Côté AA, Gagnon F, Ayotte P, Bolduc S.

Can Urol Assoc J. 2011 Jun;5(3):167-71. doi: 10.5489/cuaj.10090.

49.

Dynamic mechanical stimulations induce anisotropy and improve the tensile properties of engineered tissues produced without exogenous scaffolding.

Gauvin R, Parenteau-Bareil R, Larouche D, Marcoux H, Bisson F, Bonnet A, Auger FA, Bolduc S, Germain L.

Acta Biomater. 2011 Sep;7(9):3294-301. doi: 10.1016/j.actbio.2011.05.034. Epub 2011 May 30.

PMID:
21669302
50.

Study comparing the applicability of dorsal lumbotomy in older children.

Cloutier J, Haidar N, Rompre-Deschenes MP, Grimard M, Bolduc S.

Can Urol Assoc J. 2012 Dec;6(6):435-9. doi: 10.5489/cuaj.10064.

Supplemental Content

Loading ...
Support Center